RecruitingNot ApplicableNCT06978491

Evaluation of the Effect of Postoperative Analgesia Techniques With ObsQoR-10

Evaluation of the Effect of Postoperative Analgesia Techniques on Obstetric Recovery Quality With ObsQoR-10


Sponsor

Eskisehir Osmangazi University

Enrollment

75 participants

Start Date

May 16, 2025

Study Type

INTERVENTIONAL

Conditions

Summary

The primary objective of this study is to evaluate the effects of postoperative analgesia techniques-transversus abdominis plane (TAP) block and wound infiltration-on recovery in patients undergoing elective cesarean section, using the Obstetric Quality of Recovery-10 (ObsQoR-10) questionnaire. The secondary objective is to assess pain scores, analgesic consumption, and adverse effects such as nausea, vomiting, and pruritus within the first 24 hours postoperatively.


Eligibility

Sex: FEMALEMin Age: 18 YearsMax Age: 50 Years

Inclusion Criteria1

  • Term obstetric patients aged 18-50 years who underwent elective cesarean section under spinal anesthesia and applied regional anesthesia techniques such as TAP and wound infiltration.

Exclusion Criteria6

  • Refuse to participate in the study
  • Patients who have undergone general anesthesia
  • Patients requiring emergency cesarean section.
  • Mental status disorders
  • Known bleeding and/or coagulation disorders
  • Infection at injection site

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERGroup C

Spinal anesthesia.

OTHERGroup T

spinal anesthesia and at the end of the surgery, 20 ml 0.25% bupivacaine will be applied bilaterally between the transversus abdominis and internal oblique muscle.

OTHERGroup W

spinal anesthesia and at the end of the surgery, 20 ml 0.25% bupivacaine will be applied to the wound site.


Locations(1)

Eskisehir Osmangazi Universıty Faculty of Medicine

Eskişehir, Eski̇şehi̇r, Turkey (Türkiye)

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06978491


Related Trials